Brief: Provectus Biopharma Names Aru Narendran To Scientific Advisory Board
14/04/2022 12:35
April 14 (Reuters) - Provectus Biopharmaceuticals Inc
PVCT.PK :
* PROVECTUS BIOPHARMACEUTICALS NAMES ARU NARENDRAN, MD, PHD
TO
SCIENTIFIC ADVISORY BOARD
Source text for Eikon: ID:nGNX7z8Kkr
Further company coverage: PVCT.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Provectus Biopharmaceuticals
See all newsBrief: Provectus Biopharmaceuticals Reports Oral Pv-10 Anti-Tumor Activity In Preclinical Bladder Cancer Study
Brief: Provectus Biopharmaceuticals Initiates Preclinical Study Of Oral Pv-10
RCS - VisiRose - VisiRose Introduces Therapy for Eye Infections
RCS - FINOS - FINOS Welcomes Seven Financial Leaders
Brief: Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting